Chemspeed recently celebrated 10 full operating years with Bayer HealthCare Pharmaceuticals (Bayer) in Berlin, Germany it runs five Chemspeed instruments in its laboratories. Building on the instrument reliability, Bayer is now moving to the next generation of Chemspeed’s equipment.
Using Chemspeed SYNTHESIZER POSY platform, LyondellBasell has run a series of experiments that demonstrated that sub-milligram scale catalyst research in polyolefin synthesis is possible in a reproducible way
After implementing multiple Chemspeed platforms for various kinds of cutting edge materials research over the past 5 years, Prof. Andrew Cooper says:
Chemspeed SYNTHESIZER BIOMAT Platform helps CSIRO’s research on Drug Delivery Systems as illustrated in recent article in International Journal of Pharmaceutics
Catalyst screening is both a nightmare and the Holy Grail in selective synthesis. Companies like AstraZeneca have understood it very well. It is a nightmare because it is very difficult to predict which catalyst-ligand-solvent-additive combination and which conditions will lead to the best results
A project sponsored by Intelligent Formulation in the UK used the Chemspeed FORMAX at VLCI to gather Cc data on 22 green surfactants.
Chemspeed was recently granted a patent on Overhead Gravimetric Dispensing Technology, despite challenges from other market players